May 23, 2011 — Use of short- and long-acting inhaled anticholinergic medications (IACs) is associated with an increased risk for acute urinary retention (AUR) in men with chronic obstructive pulmonary ...

Treatment is therefore directed toward relief of symptoms and a reduction in the incidence of acute exacerbations. Within the past decade, major advances in management have been made in the ...

Clinical Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient ...

Dear Dr. Roach: I am a 73-year-old male with chronic obstructive pulmonary disease (COPD). I pretty much have it under control with medication, but I am still not able to do a whole lot, as I feel ...

DEAR DR. ROACH: I am a 73-year-old male with chronic obstructive pulmonary disease (COPD). I pretty much have it under control with medication, but I am still not able to do a whole lot, as I feel ...

Angiogram of an MI (left) and a normal coronary artery (right) Inhaled anticholinergic agents, the most common treatment for chronic obstructive pulmonary disease (COPD), may increase the risk of ...

A class of drug commonly used to treat everything from chronic obstructive pulmonary disease (COPD) to depression has now been linked to accelerating the loss of mobility in older age. This adds a new ...